Detalhe da pesquisa
1.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 121(2): 180-192, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213659
2.
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Res Treat
; 161(1): 117-134, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796716
3.
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
PLoS Genet
; 10(4): e1004256, 2014 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24698998
4.
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Res
; 17: 61, 2015 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925750
5.
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res
; 16(6): 3416, 2014 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25919761
6.
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
J Natl Cancer Inst
; 111(4): 350-364, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312457
7.
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
J Natl Cancer Inst
; 108(2)2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26586665
8.
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiol Biomarkers Prev
; 24(1): 308-16, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336561
9.
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nat Genet
; 47(2): 164-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25581431
10.
A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study.
Acta Obstet Gynecol Scand
; 83(3): 234-9, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14995917